MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with L

Lomustine

Lomustine 10mg capsules

Incompatible

Stability notes for Lomustine 10mg capsules

Cytotoxic medicine. Not recommended due to handler risk.

Suppliers

CeeNU 10mg capsules (Imported (United States))
Lomustine 10mg capsules (Special Order)

Lomustine 40mg capsules

Incompatible

Stability notes for Lomustine 40mg capsules

Cytotoxic medicine. Not recommended due to handler risk.

Suppliers

Lomustine 40mg capsules (CST Pharma Ltd)
Lomustine 40mg capsules (medac UK)

Lomustine 100mg capsules

Incompatible

Stability notes for Lomustine 100mg capsules

Cytotoxic medicine. Not recommended due to handler risk.

Suppliers

CeeNU 100mg capsules (Imported (United States))
Lomustine 100mg capsules (Special Order)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.